Investors in PROCEPT BioRobotics have until Sept 22 to act in securities lawsuit
SAN FRANCISCO, Sept. 1, 2026 /CourierPR/ -- Investors in PROCEPT BioRobotics Corporation (PRCT) have until September 22, 2026, to take action in a pending securities class action lawsuit. The case, filed after a series of unexpected sales underperformance and revelations of excess customer inventory, seeks to represent investors who purchased or otherwise acquired the company’s common stock between February 28, 2024, and February 25, 2026.
According to the lawsuit, PROCEPT and its officers are accused of violating federal securities laws by withholding crucial information from investors regarding the company’s business and financial condition. Specifically, the complaint alleges that the company engaged in a bulk discount program that incentivized customers to place large orders, pulling sales forward and artificially inflating reported unit sales and revenues.
As the allegations unfold, PROCEPT’s stock price took a significant hit. The company’s handpiece sales began to show signs of distress, with Q2 2025 financial results revealing a miss against consensus estimates by a wide margin. This was followed by Q3 2025 results that again missed expected handpiece unit sales. During the Q3 earnings call, management cited the need to optimize field inventory and acknowledged not having managed customer inventory effectively, with some customers carrying excess inventory.
In February 2026, PROCEPT disclosed that U.S. handpiece sales had materially exceeded the number of procedures in the field since Q1 2023. Cumulative excess customer inventory was over 10,000 units, and U.S. handpiece sales had sequentially cratered by 30%. Management announced the discontinuation of the bulk discount program, stating that it had been designed to drive sales in the final weeks of each quarter, but that this approach had led to an excess of inventory.
Reed Kathrein, a partner at the national shareholders rights firm Hagens Berman Sobol Shapiro LLP, commented, “Our focus is on whether PROCEPT may have intentionally pulled sales from future quarters to meet short-term expectations and whether the company was transparent enough in its investor communications.”
Hagens Berman is calling on investors who suffered substantial losses or have relevant knowledge to submit their losses now. The firm also encourages whistleblowers with non-public information about the company to come forward.
For those interested in learning more about the case and the firm’s investigation, additional information and frequently asked questions can be found at www.hbsslaw.com/prct. Whistleblowers can explore their options under the SEC Whistleblower program, which may offer rewards of up to 30 percent of any successful recovery.
Hagens Berman, a global plaintiffs' rights complex litigation firm, is leading the investigation and has a history of securing significant recoveries. The firm has represented investors, whistleblowers, workers, consumers, and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings.